The second dose of the meningitis vaccine will be available fromFeb. 17 through Feb. 20, the University announcedMondayin an email to the University community.
More than 5,200 individuals, or approximately 91 percent of the individuals eligible for the vaccine — including 93 percent of all undergraduate students — chose to receive the first dose. The second dose is a booster dose that is necessary for "maximum protection," the University said.
Make-up vaccination dates have also been added for those individuals who did not receive the first dose in December. The dates areJan. 15 and Jan. 16.
Both the make-up vaccination and the second dose will again be administered in the basement of Frist Campus Center.
The vaccine, called Bexsero and manufactured by the Swiss company Novartis, is not currently approved for use in the United States. The vaccine is being offered exclusively to University community members as an emergency response to an outbreak of meningitis type B that has affected seven students and a campus visitor since February.